Expectant management as an option for men with stage T1c prostate cancer: a preliminary study

被引:12
|
作者
Mohler, JL [1 ]
Williams, BT [1 ]
Freeman, JA [1 ]
机构
[1] Univ N Carolina, Div Urol, Dept Surg, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
10.1007/BF01300184
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The outcome of patients selecting observation of clinical stage Tie prostate cancer is unknown. A total of 101 men with clinical stage Tie prostate cancer were evaluated, counseled, and monitored in a standard fashion. Altogether, 27 men who elected observation were older and had greater co-morbidity but similar tumor characteristics as compared with 74 men who elected radical prostatectomy. In all, 9 men demonstrated clinical or biochemical evidence of progression after a mean follow-up of 23 months; 4 men who underwent radical prostatectomy had specimen-confined disease and undetectable post-operative levels of PSA. Observation appears to be a viable option for some men with clinical stage Tie prostate cancer.
引用
收藏
页码:364 / 368
页数:5
相关论文
共 50 条
  • [31] Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer
    Charles R. Pound
    Patrick C. Walsh
    Jonathan I. Epstein
    Daniel W. Chan
    Alan W. Partin
    World Journal of Urology, 1997, 15 : 373 - 377
  • [32] Clinical and pathologic significance of T1c adenocarcinoma of the prostate cancer
    BH Bochner
    DG Skinner
    G Lieskovsky
    Prostate Cancer and Prostatic Diseases, 1999, 2 : S7 - S7
  • [33] Clinical and pathologic significance of T1c adenocarcinoma of the prostate cancer
    Bochner, BH
    Skinner, DG
    Lieskovsky, G
    PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (Suppl 3) : S7 - S7
  • [34] Role of brachytherapy in patients with stage T1c, T2a adenocarcinoma of the prostate
    Chan, AJ
    Saltzman, B
    JOURNAL OF ENDOUROLOGY, 2000, 14 (04) : 319 - 324
  • [35] Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MR Imaging and MR Spectroscopic Imaging
    Zhang, Jingbo
    Hricak, Hedvig
    Shukla-Dave, Amita
    Akin, Oguz
    Ishill, Nicole M.
    Carlino, Lauren J.
    Reuter, Victor E.
    Eastham, James A.
    RADIOLOGY, 2009, 253 (02) : 425 - 434
  • [36] Prostate cancer: Are clinical stages t1c and t2 similar?
    Billis, A
    Magna, LA
    Watanabe, IC
    Costa, MV
    Telles, GHQ
    Ferreira, U
    LABORATORY INVESTIGATION, 2005, 85 : 130A - 130A
  • [37] Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: A preliminary study
    Olumi, AF
    Richie, JP
    Schultz, DJ
    D'Amico, AV
    UROLOGY, 2000, 56 (02) : 273 - 277
  • [38] Prostate cancer: Are clinical stages T1c and T2 similar?
    Billis, A
    Magna, LA
    Watanabe, IC
    Costa, MV
    Telles, GHQ
    Ferreira, U
    MODERN PATHOLOGY, 2005, 18 : 130A - 130A
  • [39] Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?
    Armatys, SA
    Koch, MO
    Bihrle, R
    Gardner, TA
    Cheng, L
    BJU INTERNATIONAL, 2005, 96 (06) : 777 - 780
  • [40] Free-to-total prostate specific antigen ratio as a single test for detection of significant stage T1c prostate cancer
    Elgamal, AAA
    Cornillie, FJ
    VanPoppel, HP
    VandeVoorde, WM
    McCabe, R
    Baert, LV
    JOURNAL OF UROLOGY, 1996, 156 (03): : 1042 - 1047